Fortress Biotech Inc. (FBIOP)
6.41
0.03 (0.47%)
At close: Mar 28, 2025, 3:13 PM
6.41
0.00%
After-hours: Mar 28, 2025, 04:00 PM EDT
Fortress Biotech Cash Flow Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 |
| Net Income | -60.64M | -213.91M | -164.83M | -102.98M | -101.66M | -130.8M | -99.84M | -71.29M | -53.88M | -20.39M | -37.16M | -27.61M | -36.36M | -9.98M |
| Depreciation & Amortization | 6M | 9.35M | 6.79M | 5.33M | 4.65M | 2.06M | 3.35M | 1.13M | 26K | 23K | 17K | 3K | 22K | 5K |
| Stock-Based Compensation | 17.03M | 22.99M | 19.49M | 13.45M | 13.19M | 15.01M | 14.01M | 12.13M | 14.29M | 5.55M | 5.9M | 3.64M | 1.47M | 2.33M |
| Other Working Capital | -4.61M | -5.43M | 756K | -4.9M | 1.53M | -680K | -6.24M | -1.39M | -701K | -684K | -127K | -138K | 1.82M | -89K |
| Other Non-Cash Items | -78.09M | 2.89M | 24.43M | 10.49M | 12.05M | 8.86M | 7.84M | 10.32M | 11.89M | 236K | 536K | 1.17M | -14.2M | 1.42M |
| Deferred Income Tax | n/a | n/a | -38.8M | -5.18M | -18.35M | 287K | -8.56M | -73K | 2.11M | -220K | n/a | n/a | 36.34M | 234K |
| Change in Working Capital | -12.52M | -715K | 36.37M | -4.78M | -4.84M | 5.74M | -2.23M | 1.97M | 5.19M | -1.53M | 1.06M | -398K | 1.77M | 318K |
| Operating Cash Flow | -128.22M | -179.4M | -116.54M | -83.68M | -94.96M | -98.85M | -85.43M | -45.81M | -20.38M | -16.33M | -29.65M | -23.19M | -10.95M | -5.68M |
| Capital Expenditures | -63K | -3.06M | -16.35M | -7.16M | -9.39M | -9.36M | -5.45M | -10.51M | -11.98M | n/a | -188K | -279K | -3.84M | -13K |
| Acquisitions | n/a | -20M | 56.86M | n/a | -1.2M | 2.27M | -19K | 4.45M | -11.7M | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | n/a | n/a | n/a | n/a | -5M | -52.6M | -56.09M | -181K | -79.95M | -23.27M | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | n/a | n/a | n/a | 22.6M | 71M | 20.09M | n/a | 99.95M | n/a | n/a | n/a | n/a | n/a |
| Other Investing Acitivies | -2.04M | 127K | 45.08M | -5.24M | 13.09M | 7.51M | -163K | -6K | 11.56M | -23.27M | -188K | -279K | -3.84M | -13K |
| Investing Cash Flow | -2.1M | -22.93M | 40.51M | -7.16M | 20.1M | 18.82M | -41.63M | -6.06M | 7.88M | -23.27M | -188K | -279K | -3.84M | -13K |
| Debt Repayment | -36.85M | 49.25M | -9.64M | -29.67M | 15M | 17.3M | 37.16M | 6.14M | 10M | 355K | -1.34M | 14.25M | n/a | -348K |
| Common Stock Repurchased | -400K | n/a | n/a | -70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.29M |
| Dividend Paid | -8.77M | -8.78M | -8.78M | -6.75M | -2.56M | -2.34M | -299K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | -2.02M | -4.3M | 12.16M | 38.3M | 5.21M | -2.57M | 18.4M | -3.33M | -6.9M | -14.01M | -836K | -2.59M | 48.68M | 19.39M |
| Financial Cash Flow | 32.74M | 75.32M | 148.99M | 172.41M | 146.71M | 50.65M | 154.21M | 41.98M | 60.92M | -10.15M | 89.16M | 40.51M | 23.09M | 19.04M |
| Net Cash Flow | -97.59M | -127.01M | 72.97M | 81.56M | 71.85M | -29.38M | 27.15M | -9.89M | 48.42M | -49.76M | 59.32M | 17.04M | 8.3M | 13.35M |
| Free Cash Flow | -136.32M | -182.46M | -132.89M | -90.85M | -104.36M | -108.2M | -90.88M | -56.32M | -32.36M | -16.33M | -29.83M | -23.47M | -14.79M | -5.69M |